All Stories

  1. HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound

    Article • Cell Reports, December 2020, Elsevier

    Dr. Rasmus Offersen

  2. Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy

    Article • Frontiers in Immunology, January 2020, Frontiers

    Dr. Rasmus Offersen

  3. Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection

    Article • Clinical Infectious Diseases, March 2017, Oxford University Press (OUP)

    Dr. Rasmus Offersen

  4. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+T Cells

    Article • Journal of Virology, February 2016, ASM Journals

    Dr. Rasmus Offersen

  5. TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults

    Article • Human Vaccines & Immunotherapeutics, August 2012, Taylor & Francis

    Dr. Rasmus Offersen

  6. Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals

    Article • PLoS ONE, June 2011, PLOS

    Dr. Rasmus Offersen

  7. Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV‐Infected Adults with a Toll‐Like Receptor 9 Agonist Adjuvant: A Randomized, Controlled Trial

    Article • Clinical Infectious Diseases, July 2010, Oxford University Press (OUP)

    Dr. Rasmus Offersen

  8. A TLR9-agonist adjuvant induces cellular memory in response to pneumococcal conjugate vaccine in HIV-infected adults

    Article • Cytokine, October 2009, Elsevier

    Dr. Rasmus Offersen